B7-H3

Hong Kong, China, September 11, 2026 Ocumension Therapeutics has announced that the National Medical Products Administration (NMPA) of China...

Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...

Limerick, Ireland, September 10, 2026 Johnson & Johnson has announced that it has received CE Marking for ACUVUE OASYS...

SEATTLE, Washington and CAMBRIDGE, Massachusetts — September 8, 2026 BrainChild Bio, Inc. announced the initiation of the pivotal Phase...

SHANGHAI, China, July 10, 2026 Hansoh Pharmaceutical Group Co., Ltd. has announced that its Phase III ARTEMIS-008 clinical trial...

Shanghai, China, May 23, 2026 Henlius Biotech has announced that the first patient has been dosed in a Phase...

BOSTON, May 04, 2026 Aktis Oncology has announced the initiation of a Phase 1b clinical trial evaluating AKY-2519, a...

Tokyo, Japan & Basking Ridge, New Jersey | April 13, 2026 Daiichi Sankyo, in collaboration with Merck & Co.,...